PEACHES BIOTECH: Clinical Trials

1 trial sponsored by PEACHES BIOTECH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow PEACHES BIOTECH: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
Placebo comparator, PRS CK STORM - SARS-CoV-2, Influenza, Human
Phase 1 / Phase 2RecruitingPEACHES BIOTECH502024-10-022026-06-10

Conditions studied

COVID-19 (1)  ·  Cytokine Release Syndrome (1)  ·  Influenza, Human (1)  ·  Lung Diseases (1)  ·  Pneumonia (1)  ·  Respiratory Distress Syndrome (1)  ·  Respiratory Syncytial Virus Infections (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Saline Solution (1)

Countries

Spain (1)

Top investigators

David Bernal, Dr. (1)

Results publications

PMID 35454123

NIH funding

2023 (1)